GFR90 Revenue

Medical Equipment Manufacturing • London, Ontario, Canada • 1-10 Employees

GFR90 revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$821,328
Total funding	No funding

Key Contact at GFR90

Don Bilyea

Chief Executive Officer

Company overview

Headquarters	3818 Deer Trail, London, ON N6P 1E6, CA
Website	gfr90.com
Founded	2020
Employees	1-10

GFR90 Email Formats

GFR90 uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@gfr90.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@gfr90.com	100%

About GFR90

GFR90 was formed to commercialize and further develop a WEARABLE ARTIFICIAL KIDNEY. This award-winning device has been in development for over eight years, has patents in Canada, USA and other regions, and has been successfully used with dialysis patients. There are over 800,000 dialysis patients in North America. Most of these must attend a dialysis clinic or hospital two to three times a week for dialysis because they suffer from end stage kidney disease, that is, their kidneys no longer work effectively. Although this is life-saving therapy, this intermittency creates medical, social, and mental health issues which result in reduced quality and length of life. Patients feel lethargy, nausea, and fatigue so much so that holding a full time job or attending school is very difficult. The solution is to change dialysis from an intermittent therapy to a continuous therapy - just like healthy kidneys. This will smooth out the fluid accumulation and relieve the work overload it causes on the heart. The intermittency issues with current dialysis are so severe that the FDA and the US White House have issued statements to try to address them by encouraging industry to solve the problem. GFR90 has the solution: a wearable dialysis machine that is lightweight and battery operated so patients wear it during normal activities every day - activities like preparing dinner, gardening, or attending a concert. This near continuous dialysis functions more like healthy kidneys and attenuates the huge swings in body fluids. Scheduled to enter the market in North America within 3 years with their first wearable artificial kidney, GFR90 is further development and commercialization stages of this remarkable device. If you are interested in knowing more, please go to www.GFR90.com. or contact Norm Tiffin at norm.tiffin@gfr90.com.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

GFR90 has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

GFR90 has never raised funding before.

GFR90 Tech Stack

Discover the technologies and tools that power GFR90's digital infrastructure, from frameworks to analytics platforms.

Emotion

Development

Next.js

JavaScript frameworks

HSTS

Security

React

JavaScript frameworks

Webpack

Miscellaneous

Vercel

PaaS

Priority Hints

Performance

Microsoft 365

Frequently asked questions

GFR90 is located in London, Ontario, CA.

GFR90 generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

GFR90 has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

GFR90 was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

GFR90 has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at GFR90

Don Bilyea

Chief Executive Officer

4.8

40,000 users